TactiFlex Paroxysmal Atrial Fibrillation IDE Trial

A patient will be eligible for clinical trial participation if he/she meets the following criteria: 1. Plans to undergo a catheter ablation procedure due to symptomatic paroxysmal atrial fibrillation 2. Physician's note indicating recurrent self-terminating atrial fibrillation 3. One electrocardiographically documented atrial fibrillation episode within 12-months prior to informed consent/enrollment. Documented evidence of the atrial fibrillation episode must either be continuous atrial fibrillation on a 12-lead ECG or include at least 30 seconds of atrial fibrillation from another ECG device. 4. At least 18 years of age 5. Able and willing to comply with all trial requirements 6. Informed of the nature of the trial, agreed to its provisions and has provided written informed consent as approved by the Institutional Review Board/Ethics Committee of the respective clinical trial site. A patient will be excluded from enrollment in the clinical trial if he/she meets any of the following criteria: 1. Persistent or long-standing persistent atrial fibrillation 2. Active systemic infection 3. Known presence of cardiac thrombus 4. Hypertrophic cardiomyopathy 5. Arrhythmia due to reversible causes including thyroid disorders, acute alcohol intoxication, and other major surgical procedures in the 90-day period preceding procedure 6. Myocardial infarction, acute coronary syndrome, percutaneous coronary intervention, or valve or coronary bypass grafting surgery within 90 days of proced…